Mining biomarkers for type 2 diabetic nephropathy based on urinary proteomics and metabolomics - Top-Institutions - MDSpire

Mining biomarkers for type 2 diabetic nephropathy based on urinary proteomics and metabolomics

  • By

  • Mindong Mi

  • Tianhuan Xiong

  • Jiyong Gong

  • Weijie Sun

  • Tunguang Xu

  • Qifeng Jiang

  • Danqing Zhang

  • Junge Zhang

  • Jiancheng Huang

  • Wei Liang

  • June 22, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Ningbo University Affiliated First Hospital
    Ningbo University Affiliated First Hospital

    Ningbo, Zhejiang

    Key Differentiators

    • Nephrology

  • #2

    Singapore
    Singapore

    Singapore, Singapore

    Key Differentiators

    • Nephrology

  • #3

    Swedish CArdioPulmonary BioImage Study
    Swedish CArdioPulmonary BioImage Study

    Sweden, Sweden

    Key Differentiators

    • Nephrology

  • #4

    China Kadoorie Biobank
    China Kadoorie Biobank

    China, China

    Key Differentiators

    • Nephrology

  • #5

    Kidney Precision Medicine Project
    Kidney Precision Medicine Project

    USA, USA

    Key Differentiators

    • Nephrology

Original Source(s)

Mining biomarkers for type 2 diabetic nephropathy based on urinary proteomics and metabolomics

  • by Mindong Mi, Tianhuan Xiong, Jiyong Gong, Weijie Sun, Tunguang Xu, Qifeng Jiang, Danqing Zhang, Junge Zhang, Jiancheng Huang, Wei Liang

  • June 22, 2026

Related Content

Utilizing Machine Learning to Identify Risk Factors for Diabetic Microvascular Complications and Develop a Predictive Model with Gradient Boosting Decision Trees

Early Proteomic and Metabolomic Signatures in Diabetes Associated with Progression to Diabetic Retinopathy Over 1–2 Years

Assessment of Two-Phase Diagnostic Timelines in Diabetic Retinopathy and Contributing Factors: A Cross-Sectional Analysis